Cardiff, United Kingdom

Christopher Pepper

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Neuro-Bio Ltd. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Pepper. Retrieved from https://idiyas.com/inventor/christopher-pepper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher Pepper: Innovator in Cancer Treatment

Introduction

Christopher Pepper is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of two patents to his name, Pepper is dedicated to advancing medical science.

Latest Patents

Pepper's latest patents focus on the use of cyclic acetylcholinesterase C-terminal peptides in the treatment or prevention of cancer and metastasis. These inventions relate to cyclic polypeptides derived from the C-terminus of acetylcholinesterase, which are designed for use in treating or preventing cancer or metastatic disease. His work in this area highlights the potential for new therapeutic approaches in oncology.

Career Highlights

Christopher Pepper is currently associated with Neuro-Bio Ltd, where he continues to push the boundaries of medical research. His expertise and innovative mindset have positioned him as a key player in the development of novel cancer treatments.

Collaborations

Pepper collaborates with Susan Adele Greenfield, a respected figure in the field. Their partnership exemplifies the importance of teamwork in driving forward scientific advancements.

Conclusion

Christopher Pepper's contributions to cancer treatment through his innovative patents and collaborations underscore his commitment to improving patient outcomes. His work continues to inspire future research in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…